Serum vascular endothelial growth factor receptor-2 and adropin levels in age-related macular degeneration
AIM: To investigate the serum levels of vascular endothelial growth factor receptor-2 (VEGFR-2) and adropin in age-related macular degeneration (AMD) patients. METHODS: Ninety-eight AMD patients were included in the study. Seventy-eight age- and sex-matched healthy volunteers were recruited as the...
Main Authors: | Nurgül Örnek, Kemal Örnek, Süleyman Aydin, Musa Yilmaz, Yaşar Ölmez |
---|---|
Format: | Article |
Language: | English |
Published: |
Press of International Journal of Ophthalmology (IJO PRESS)
2016-04-01
|
Series: | International Journal of Ophthalmology |
Subjects: | |
Online Access: | http://www.ijo.cn/en_publish/2016/4/20160413.pdf |
Similar Items
-
Serum adropin level in wet-type age-related macular degeneration
by: Zahra Saeedi-Maleki, et al.
Published: (2024-03-01) -
Diagnostic Value of Adropin Levels in Acute Pulmonary Embolism Patients
by: Mustafa Kürşat Ayrancı, et al.
Published: (2020-09-01) -
Current advance in the application of anti-vascular endothelial growth factor drugs in wet age-related macular degeneration
by: Ling-Yi Ouyang, et al.
Published: (2020-01-01) -
Elevated tumor necrosis factor alpha and vascular endothelial growth factor in intermediate age-related macular degeneration and geographic atrophy
by: Vivian Rajeswaren, et al.
Published: (2024-03-01) -
Subgroups and Features of Poor Responders to Anti-Vascular Endothelial Growth Factor Treatment in Eyes with Neovascular Age-Related Macular Degeneration
by: Mine Esen Barış, et al.
Published: (2020-10-01)